Follow
Mark Y. Chan
Mark Y. Chan
National University Heart Centre Singapore
Verified email at nus.edu.sg
Title
Cited by
Cited by
Year
Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy
PA Gurbel, D Erlinge, EM Ohman, B Neely, M Neely, SG Goodman, ...
Jama 308 (17), 1785-1794, 2012
2662012
Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction
MY Chan, JL Sun, LK Newby, LK Shaw, M Lin, ED Peterson, RM Califf, ...
Circulation 119 (24), 3110-3117, 2009
2662009
Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention
CH Lee, R Sethi, R Li, HH Ho, T Hein, MH Jim, G Loo, CY Koo, XF Gao, ...
Circulation 133 (21), 2008-2017, 2016
1692016
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching …
S Brugaletta, T Gori, AF Low, P Tousek, E Pinar, J Gomez-Lara, ...
JACC: Cardiovascular Interventions 8 (1 Part B), 189-197, 2015
1572015
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease
MY Chan, MG Cohen, CK Dyke, SK Myles, LG Aberle, M Lin, J Walder, ...
Circulation 117 (22), 2865-2874, 2008
1552008
Hypercoagulable states in cardiovascular disease
MY Chan, F Andreotti, RC Becker
Circulation 118 (22), 2286-2297, 2008
1412008
Severe obstructive sleep apnea and outcomes following myocardial infarction
CH Lee, SM Khoo, MY Chan, HB Wong, AF Low, QH Phua, AM Richards, ...
Journal of Clinical Sleep Medicine 7 (6), 616-621, 2011
1182011
A randomized, repeat‐dose, pharmacodynamic and safety study of an antidote‐controlled factor IXa inhibitor
MY Chan, CP Rusconi, JH Alexander, RM Tonkens, RA Harrington, ...
Journal of Thrombosis and Haemostasis 6 (5), 789-796, 2008
1152008
Acute coronary syndrome in the Asia-Pacific region
MY Chan, X Du, D Eccleston, C Ma, PP Mohanan, M Ogita, KG Shyu, ...
international Journal of Cardiology 202, 861-869, 2016
1122016
Coronavirus-induced myocarditis: a meta-summary of cases
JSY Ho, CH Sia, MYY Chan, W Lin, RCC Wong
Heart & Lung 49 (6), 681-685, 2020
1072020
First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention
MG Cohen, DA Purdy, JS Rossi, LR Grinfeld, SK Myles, LH Aberle, ...
Circulation 122 (6), 614-622, 2010
932010
Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study
CH Lee, A Low, BC Tai, M Co, MY Chan, J Lim, YT Lim, HC Tan
European heart journal 28 (1), 19-25, 2007
742007
Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous …
H Bulluck, MHH Chan, V Paradies, RL Yellon, HH Ho, MY Chan, ...
Journal of Cardiovascular Magnetic Resonance 20 (1), 1-10, 2018
722018
Prevalence, predictors, and impact of conservative medical management for patients with non–ST-segment elevation acute coronary syndromes who have angiographically documented …
MY Chan, KW Mahaffey, LJ Sun, KS Pieper, HD White, PE Aylward, ...
JACC: Cardiovascular Interventions 1 (4), 369-378, 2008
722008
Effect on bleeding, time to revascularization, and one-year clinical outcomes of the radial approach during primary percutaneous coronary intervention in patients with ST …
D Arzamendi, HQ Ly, JF Tanguay, MYY Chan, P Chevallereau, R Gallo, ...
The American journal of cardiology 106 (2), 148-154, 2010
702010
Antecedent risk factors and their control in young patients with a first myocardial infarction
MY Chan, KS Woo, HB Wong, BL Chia, A Sutandar, HC Tan
Singapore medical journal 47 (1), 27, 2006
692006
Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI).
T Kajiya, M Liang, RK Sharma, CH Lee, MY Chan, E Tay, KH Chan, ...
EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2013
682013
Plasma ceramides as prognostic biomarkers and their arterial and myocardial tissue correlates in acute myocardial infarction
LP de Carvalho, SH Tan, GS Ow, Z Tang, J Ching, JP Kovalik, SC Poh, ...
JACC: Basic to Translational Science 3 (2), 163-175, 2018
662018
The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease
HK Kim, US Tantry, SC Smith Jr, MH Jeong, SJ Park, MH Kim, DS Lim, ...
Thrombosis and haemostasis 121 (04), 422-432, 2021
632021
The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease
IEM Bank, L Timmers, CM Gijsberts, YN Zhang, A Mosterd, JW Wang, ...
Expert review of molecular diagnostics 15 (12), 1577-1588, 2015
492015
The system can't perform the operation now. Try again later.
Articles 1–20